Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 17/20 | 0.70 |
| ▸ | CYP2C9 | P11712 | 11/20 | 0.70 |
| ▸ | CYP2C19 | P33261 | 11/20 | 0.70 |
| ▸ | LMNA | P02545 | 2/20 | 0.70 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.70 |
| ▸ | CYP3A5 | P20815 | 1/20 | 0.70 |
| ▸ | CYP3A7 | P24462 | 1/20 | 0.70 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.70 |
| ▸ | CYP3A43 | Q9HB55 | 1/20 | 0.70 |
| ▸ | CYP46A1 | Q9Y6A2 | 1/20 | 0.70 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.69 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.69 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.69 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.69 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.69 |
| ▸ | CYP51A1 | Q16850 | 1/20 | 0.69 |
| ▸ | CYP1A2 | P05177 | 6/20 | 0.64 |
| ▸ | CYP2D6 | P10635 | 6/20 | 0.64 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.59 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30485092 | 1.00 | CYP3A4 (0.70) | CYP3A4CYP2C9CYP2C19LMNACYP2B6 | |
| SCHEMBL7478959 | 1.00 | CYP3A4 (0.70) | CYP3A4CYP2C9CYP2C19LMNACYP2B6 | |
| SCHEMBL1824105 | 1.00 | CYP3A4 (0.70) | CYP3A4CYP2C9CYP2C19LMNACYP2B6 | |
| SCHEMBL7537507 | 1.00 | CYP3A4 (0.70) | CYP3A4CYP2C9CYP2C19LMNACYP2B6 | |
| SCHEMBL18717940 | 1.00 | CYP3A4 (0.70) | CYP3A4CYP2C9CYP2C19LMNACYP2B6 | |
| SCHEMBL2912761 | 1.00 | CYP3A4 (0.70) | CYP3A4CYP2C9CYP2C19LMNACYP2B6 | |
| SCHEMBL10597737 | 1.00 | CYP3A4 (0.70) | CYP3A4CYP2C9CYP2C19LMNACYP2B6 | |
| SCHEMBL29357899 | 0.93 | CYP3A4 (0.63) | CYP3A4CYP2C9CYP2C19LMNACYP2B6 | |
| SCHEMBL28847757 | 0.93 | CYP3A4 (0.63) | CYP3A4CYP2C9CYP2C19LMNACYP2B6 | |
| SCHEMBL28847754 | 0.93 | CYP3A4 (0.63) | CYP3A4CYP2C9CYP2C19LMNACYP2B6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9617241-B2 | Intermediate compounds and process for the preparation of efinaconazole | MAPI PHARMA LTD. (IL) | 2017-04-11 | — | — | US | disclosed |
| US-9617241-B2 | Intermediate compounds and process for the preparation of efinaconazole | MAPI PHARMA LTD. (IL) | 2017-04-11 | — | — | US | disclosed |
| US-20160355500-A1 | INTERMEDIATE COMPOUNDS AND PROCESS FOR THE PREPARATION OF EFINACONAZOLE | MAPI PHARMA LTD. (IL) | 2016-12-08 | — | — | US | disclosed |
| US-20160355500-A1 | INTERMEDIATE COMPOUNDS AND PROCESS FOR THE PREPARATION OF EFINACONAZOLE | MAPI PHARMA LTD. (IL) | 2016-12-08 | — | — | US | disclosed |
| WO-2016079728-A1 | INTERMEDIATE COMPOUNDS AND PROCESS FOR THE PREPARATION OF EFINACONAZOLE | MAPI PHARMA LTD. (IL) | 2016-05-26 | — | — | WO | disclosed |
| EP-1535914-B1 | PROCESSES FOR PRODUCING EPOXYTRIAZOLE DERIVATIVE AND INTERMEDIATE THEREFOR | SUMITOMO CHEMICAL CO (JP) | 2011-11-02 | — | — | EP | disclosed |
| US-7297802-B2 | Production methods of epoxytriazole derivative and intermediate therefor | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-11-20 | — | — | US | disclosed |
| EP-1535914-A1 | PROCESSES FOR PRODUCING EPOXYTRIAZOLE DERIVATIVE AND INTERMEDIATE THEREFOR | Sumitomo Chemical Company, Limited (JP) | 2005-06-01 | — | — | EP | disclosed |
| US-6884892-B2 | Production methods of epoxytriazole derivative and intermediate therefor | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-04-26 | — | — | US | disclosed |
| US-20040267024-A1 | Production methods of epoxytriazole derivative and intermediate therefor | SUMIKA FINE CHEMICALS CO., LTD. (JP) | 2004-12-30 | — | — | US | disclosed |
| US-20030236419-A1 | Production methods of epoxytriazole derivative and intermediate therefor | SUMIKA FINE CHEMICALS CO., LTD. (JP) | 2003-12-25 | — | — | US | disclosed |
| EP-1071640-B1 | ASYMMETRIC SYNTHESIS OF 2-ARYL-1-SUBSTITUTED BUTAN-2,3-DIOLS | NAEJA PHARMACEUTICAL INC (CA) | 2002-03-13 | — | — | EP | disclosed |
| EP-1071640-A1 | ASYMMETRIC SYNTHESIS OF 2-ARYL-1-SUBSTITUTED BUTAN-2,3-DIOLS | Naeja Pharmaceutical Inc. (CA) | 2001-01-31 | — | — | EP | disclosed |
| US-6133485-A | Asymmetric synthesis of 2-(2,4-difluorophenyl)-1-heterocycl-1-yl butan-2,3-diols | SYNPHAR LABORATORIES, INC. (CA) | 2000-10-17 | — | — | US | disclosed |
| WO-1999052840-A1 | ASYMMETRIC SYNTHESIS OF 2-ARYL-1-SUBSTITUTED BUTAN-2,3-DIOLS | NAEJA PHARMACEUTICAL INC. (US) | 1999-10-21 | — | — | WO | disclosed |
| EP-0728752-A1 | Triazole compounds, their production and use | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-08-28 | — | — | EP | disclosed |
| US-5405861-A | Fungicides | TAKEDA CHEMICAL INDUSTRIES, CO., LTD. (JP) | 1995-04-11 | — | — | US | disclosed |
| EP-0421210-A2 | Triazole compounds, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1991-04-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040267024-A1 | Production methods of epoxytriazole derivative and intermediate therefor | ERG28, CYP51A1, SOAT2 | CYP3A4 185/4885CYP2C9 1396/4885CYP2C19 2087/4885 |
| US-20030236419-A1 | Production methods of epoxytriazole derivative and intermediate therefor | ERG28, CYP51A1, SOAT2 | CYP3A4 185/4885CYP2C9 1396/4885CYP2C19 2087/4885 |
| US-20160355500-A1 | INTERMEDIATE COMPOUNDS AND PROCESS FOR THE PREPARATION OF EFINACONAZOLE | CYP2E1, CYP3A4, CYP4B1 | CYP3A4 2/4885CYP2C9 41/4885CYP2C19 36/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.